Peptide record

TPDB07012

Antibacterial Anticancer Antifungal Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07012
Antibacterial Anticancer Antifungal Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 Antifungipept CAFPdb
standard
No
A 13-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FLYIVAKLLSGLL
Physicochemical Analysis
C73H120N14O16
RNDCEQHMPTW
L
1449.84
9.74
1
0
10
+1
-4.15
1.992
210.00
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
1490
102.77
2
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
1
I
5
L
1
K
0
M
1
F
0
P
1
S
0
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 1 L: 5 K: 1 M: 0 F: 1 P: 0 S: 1 T: 0 W: 0 Y: 1 V: 1
Chemical Descriptors
13
C73H120N14O16
1449.84
9.74
+1
-4.15
1.992
Evidence Records 3 records
Evidence 1 Activity

Activity

IC50
Toxicity
40.30 µM
Cytotoxic
IC50 | 40.30 | µM | target cell: Human microvascular endothelial cells HMEC-1

Target

Human microvascular endothelial cells HMEC-1

Source & Reference

NA
DBAASP
Identification and target-modifications of temporin-PE: A novel antimicrobial peptide in the defensive skin secretions of the edible frog, Pelophylax kl. esculentus. | Biochem Biophys Res Commun | 2017
Evidence 2 Activity

Activity

50% Hemolysis
Toxicity
526.5 µM
Hemolytic Cytotoxic
50% Hemolysis | 526.5 | µM | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
Identification and target-modifications of temporin-PE: A novel antimicrobial peptide in the defensive skin secretions of the edible frog, Pelophylax kl. esculentus. | Biochem Biophys Res Commun | 2017
Evidence 3 Activity

Activity

HC50
Toxicity
531.7 µM
Hemolytic
Hemolytic_activity: [Ref.29191658]HC50=531.7 µM against horse red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochem Biophys Res Commun. 2018 Jan 22 495(4):2539-2546.